mitomycin has been researched along with Ascites, Gelatinous in 72 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 7.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| "To apply (HIPEC) using mitomycin in patients with peritoneal carcinomatosis." | 3.70 | [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute]. ( Beijnen, JH; Boot, H; Kaag, MM; van der Vange, N; Witkamp, AJ; Zoetmulder, FA, 1999) |
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 3.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| "Mucinous appendiceal neoplasms (MANs) are rare tumours and the primary cause of pseudomyxoma peritonei." | 2.66 | Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review. ( Alshahrani, MS; Lansom, J; Morris, DL; Soucisse, ML, 2020) |
| "Management of peritoneal disease from appendiceal neoplasms has historically been with debulking surgery." | 2.61 | Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms. ( Craig Lynch, A; Heriot, A; Michael, M; Narasimhan, V; Pham, T; Ramsay, R; Tie, J; Warrier, S, 2019) |
| " The study is to analyze the incidence of perioperative serious adverse events (SAEs) of CRS + HIPEC to treat PMP patients, and identify the risk factors, for guiding the prevention of SAEs." | 1.56 | Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. ( Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J, 2020) |
| "Pseudomyxoma peritonei is rare, almost always of appendiceal origin, and presents in various ways relevant to abdominal surgeons." | 1.56 | Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei. ( Cecil, TD; Chandrakumaran, K; Dayal, S; Mohamed, F; Moran, BJ; Shariff, US, 2020) |
| "Pseudomyxoma peritonei is a disease that results from a perforated mucinous neoplasm of the appendix so that mucinous ascites and mucin-producing tumor cells are widely disseminated in a characteristic pattern throughout the abdomen and pelvis." | 1.46 | Management of an inguinal hernia in patients with pseudomyxoma peritonei. ( Sugarbaker, PH, 2017) |
| "Pseudomyxoma peritonei was the primary indication, and a glissonectomy was more frequently performed for patients with high peritoneal cancer index." | 1.43 | Digital Glissonectomy: A Safe Perihepatic Peritonectomy. ( Bakrin, N; Bonnefoy, I; Cotte, E; Glehen, O; Kepenekian, V; Kim, BJ; Passot, G; Vaudoyer, D, 2016) |
| "Mitomycin C (88." | 1.40 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. ( Hiotis, S; Jibara, G; Labow, DM; Romanoff, A; Sarpel, U; Shrager, B; Tabrizian, P; Yang, MJ, 2014) |
| "Patients with PC from colorectal or appendiceal cancer, pseudomyxoma peritonei or malignant peritoneal mesothelioma referred to the single national HIPEC centre were prospectively registered from June 2006 to July 2012." | 1.39 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. ( Hagemann-Madsen, R; Iversen, LH; Laurberg, S; Rasmussen, PC, 2013) |
| "Pseudomyxoma peritonei and peritoneal carcinomatosis derived from appendiceal epithelial tumors are controversial entities from classification to treatment." | 1.39 | Controversy and consensus on the management of patients with pseudomyxoma peritonei. ( Faris, JE; Ryan, DP, 2013) |
| "Pseudomyxoma peritonei is a diffuse peritoneal malignancy that generally originates form a perforated appendiceal tumor." | 1.39 | Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. ( Cecil, TD; Chandrakumaran, K; Dayal, S; Mohamed, F; Moran, BJ; Riss, S; Taflampas, P, 2013) |
| "Pseudomyxoma peritonei is a rare disease." | 1.33 | Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. ( Bossard, N; Brigand, C; Causeret, S; Faheez, M; Gilly, F; Glehen, O; Loungnarath, R; Sayag-Beaujard, AC, 2005) |
| "Diffuse pyogenic gelatinous ascites and a large cystic mass with a grayish wall, and a hard solid lesion in part were found." | 1.31 | Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case. ( Kuroki, Y; Otagiri, S; Tsukada, K, 2001) |
| "Pseudomyxoma peritonei is a rare disease caused by a perforated adenoma of the appendix." | 1.29 | Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. ( Sugarbaker, PH; Zoetmulder, FA, 1996) |
| "Pseudomyxoma peritonei is an unusual malignancy arising from the goblet cells of the large bowel or appendix." | 1.27 | Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. ( Kern, K; Lack, E; Sugarbaker, PH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.39) | 18.7374 |
| 1990's | 9 (12.50) | 18.2507 |
| 2000's | 24 (33.33) | 29.6817 |
| 2010's | 30 (41.67) | 24.3611 |
| 2020's | 8 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fernando, D | 1 |
| Larach, JT | 1 |
| Flood, MP | 1 |
| Warrier, SK | 1 |
| McCormick, JJ | 1 |
| Heriot, AG | 1 |
| Waters, PS | 1 |
| Ghelardi, F | 1 |
| Raimondi, A | 1 |
| Morano, F | 1 |
| Randon, G | 1 |
| Pannone, A | 1 |
| Guaglio, M | 1 |
| Mazzoli, G | 1 |
| Nasca, V | 1 |
| Milione, M | 1 |
| Leoncini, G | 1 |
| Sabella, G | 1 |
| Greco, GF | 1 |
| Lampis, BR | 1 |
| Galassi, M | 1 |
| Delfanti, S | 1 |
| Nannini, M | 1 |
| Intini, R | 1 |
| Baratti, D | 5 |
| Di Bartolomeo, M | 1 |
| Deraco, M | 6 |
| Pietrantonio, F | 1 |
| Sørensen, O | 1 |
| Andersen, AM | 1 |
| Larsen, SG | 2 |
| Giercksky, KE | 1 |
| Flatmark, K | 1 |
| Li, XB | 1 |
| Ma, R | 1 |
| Ji, ZH | 1 |
| Lin, YL | 1 |
| Zhang, J | 1 |
| Yang, ZR | 1 |
| Chen, LF | 1 |
| Yan, FC | 1 |
| Li, Y | 1 |
| Kawaguchi, Y | 1 |
| Hanaoka, J | 1 |
| Soucisse, ML | 1 |
| Lansom, J | 1 |
| Alshahrani, MS | 1 |
| Morris, DL | 4 |
| Shariff, US | 1 |
| Chandrakumaran, K | 6 |
| Dayal, S | 2 |
| Mohamed, F | 6 |
| Cecil, TD | 4 |
| Moran, BJ | 4 |
| Arjona-Sanchez, A | 2 |
| Aziz, O | 1 |
| Passot, G | 3 |
| Salti, G | 1 |
| Esquivel, J | 1 |
| Van der Speeten, K | 1 |
| Piso, P | 2 |
| Nedelcut, DS | 1 |
| Sommariva, A | 1 |
| Yonemura, Y | 2 |
| Turaga, K | 1 |
| Selvasekar, CR | 1 |
| Rodriguez-Ortiz, L | 1 |
| Sanchez-Hidalgo, JM | 1 |
| Casado-Adam, A | 2 |
| Rufian-Peña, S | 2 |
| Briceño, J | 1 |
| Glehen, O | 5 |
| Lococo, F | 1 |
| Di Giorgio, A | 1 |
| Iaffaldano, A | 1 |
| Schinzari, G | 1 |
| Tabacco, D | 1 |
| Aceto, P | 1 |
| Abatini, C | 1 |
| Sollazzi, L | 1 |
| Margaritora, S | 1 |
| Ashraf-Kashani, N | 1 |
| Bell, J | 1 |
| Rana, AKS | 1 |
| Agarwal, N | 1 |
| Dutta, S | 1 |
| Dokania, MK | 1 |
| Goyal, H | 1 |
| Thorgersen, EB | 1 |
| Melum, E | 1 |
| Folseraas, T | 1 |
| Line, PD | 1 |
| García, KM | 1 |
| Flores, KM | 1 |
| Ruiz, A | 1 |
| González, FL | 1 |
| Rodríguez, ÁM | 1 |
| Narasimhan, V | 1 |
| Pham, T | 1 |
| Warrier, S | 1 |
| Craig Lynch, A | 1 |
| Michael, M | 1 |
| Tie, J | 1 |
| Ramsay, R | 1 |
| Heriot, A | 1 |
| Iversen, LH | 1 |
| Rasmussen, PC | 1 |
| Hagemann-Madsen, R | 1 |
| Laurberg, S | 1 |
| Kusamura, S | 5 |
| Hutanu, I | 1 |
| Faris, JE | 1 |
| Ryan, DP | 1 |
| Järvinen, P | 1 |
| Ristimäki, A | 1 |
| Kantonen, J | 1 |
| Lepistö, A | 1 |
| Taflampas, P | 1 |
| Riss, S | 1 |
| Bakrin, N | 2 |
| Roux, AS | 1 |
| Vaudoyer, D | 2 |
| Gilly, FN | 1 |
| Cotte, E | 2 |
| Tabrizian, P | 1 |
| Shrager, B | 1 |
| Jibara, G | 1 |
| Yang, MJ | 1 |
| Romanoff, A | 1 |
| Hiotis, S | 1 |
| Sarpel, U | 1 |
| Labow, DM | 1 |
| Lord, AC | 1 |
| Shihab, O | 1 |
| Liu, Y | 1 |
| Ishibashi, H | 1 |
| Hirano, M | 1 |
| Takeshita, K | 1 |
| Mizumoto, A | 1 |
| Ichinose, M | 1 |
| Nishino, E | 1 |
| Kashu, I | 1 |
| Yamamoto, Y | 1 |
| Sugarbaker, PH | 10 |
| Moran, B | 3 |
| Cecil, T | 2 |
| Arnold, S | 1 |
| Venkatasubramaniam, A | 1 |
| Roberts, DL | 1 |
| O'Dwyer, ST | 2 |
| Stern, PL | 1 |
| Renehan, AG | 2 |
| Sabourin, JC | 1 |
| Bjersand, K | 1 |
| Mahteme, H | 1 |
| Sundström Poromaa, I | 1 |
| Andréasson, H | 1 |
| Graf, W | 1 |
| Larsson, R | 1 |
| Nygren, P | 1 |
| Bouhadjari, N | 1 |
| Gabato, W | 1 |
| Calabrese, D | 1 |
| Msika, S | 1 |
| Keita, H | 1 |
| Kuijpers, AM | 1 |
| Hauptmann, M | 1 |
| Aalbers, AG | 1 |
| Nienhuijs, SW | 1 |
| de Hingh, IH | 1 |
| Wiezer, MJ | 1 |
| van Ramshorst, B | 1 |
| van Ginkel, RJ | 1 |
| Havenga, K | 1 |
| Verwaal, VJ | 2 |
| Kim, BJ | 1 |
| Kepenekian, V | 1 |
| Bonnefoy, I | 1 |
| Di Fabio, F | 1 |
| Mehta, A | 1 |
| Mahmoud, AM | 1 |
| Hussein, MM | 1 |
| Moneer, MM | 1 |
| Farquharson, AL | 1 |
| Pranesh, N | 1 |
| Witham, G | 1 |
| Swindell, R | 1 |
| Taylor, MB | 1 |
| Rout, S | 1 |
| Wilson, MS | 1 |
| Saunders, MP | 1 |
| Nonaka, D | 2 |
| Cabras, AD | 1 |
| Laterza, B | 3 |
| Mirnezami, AH | 1 |
| Senthil, M | 1 |
| Harrison, LE | 1 |
| Elias, D | 1 |
| Gilly, F | 2 |
| Quenet, F | 1 |
| Bereder, JM | 1 |
| Sidéris, L | 1 |
| Mansvelt, B | 1 |
| Lorimier, G | 1 |
| Chua, TC | 2 |
| Al-Zahrani, A | 1 |
| Saxena, A | 1 |
| Liauw, W | 2 |
| Zhao, J | 1 |
| Muñoz-Casares, FC | 1 |
| Díaz-Nieto, R | 1 |
| Rubio-Pérez, MJ | 1 |
| Ortega-Salas, R | 1 |
| Kitai, T | 1 |
| Kawashima, M | 1 |
| Yamanaka, K | 1 |
| Ichijima, K | 1 |
| Fujii, H | 1 |
| Mashima, S | 1 |
| Shimahara, Y | 1 |
| Gething, S | 1 |
| Haiba, M | 1 |
| Brun, EA | 1 |
| Güner, Z | 1 |
| Schmidt, U | 1 |
| Dahlke, MH | 1 |
| Schlitt, HJ | 1 |
| Klempnauer, J | 1 |
| Loungnarath, R | 1 |
| Causeret, S | 1 |
| Bossard, N | 1 |
| Faheez, M | 1 |
| Sayag-Beaujard, AC | 1 |
| Brigand, C | 1 |
| Alexander-Sefre, F | 1 |
| Banerjee, S | 1 |
| Sexton, R | 1 |
| Thomas, JM | 1 |
| Mizuta, Y | 1 |
| Akazawa, Y | 1 |
| Shiozawa, K | 1 |
| Ohara, H | 1 |
| Ohba, K | 1 |
| Ohnita, K | 1 |
| Isomoto, H | 1 |
| Takeshima, F | 1 |
| Omagari, K | 1 |
| Tanaka, K | 1 |
| Yasutake, T | 1 |
| Nakagoe, T | 1 |
| Shirono, K | 1 |
| Kohno, S | 1 |
| Smeenk, RM | 1 |
| Zoetmulder, FA | 4 |
| De Simone, M | 1 |
| Rossi, CR | 1 |
| Cavaliere, F | 1 |
| Di Filippo, F | 1 |
| Vaira, M | 1 |
| Piatti, P | 1 |
| Yan, TD | 1 |
| Links, M | 1 |
| Xu, ZY | 1 |
| Kam, PC | 1 |
| Glenn, D | 1 |
| Qu, ZB | 1 |
| Liu, LX | 1 |
| Dang, A | 1 |
| Mansfield, P | 1 |
| Ilsin, B | 1 |
| Hightower, C | 1 |
| Aravindan, N | 1 |
| Rice, D | 1 |
| Riedel, B | 1 |
| González-Moreno, S | 1 |
| Lambert, LA | 1 |
| Mansfield, PF | 1 |
| Martinetti, A | 1 |
| Seregni, E | 1 |
| Oliva, DG | 1 |
| Langer, M | 1 |
| Andreola, S | 1 |
| Favaro, M | 1 |
| Gavazzi, C | 1 |
| Sasaki, A | 2 |
| Terashima, M | 2 |
| Okamoto, K | 2 |
| Ikeda, K | 2 |
| Takagane, A | 2 |
| Takiyama, I | 2 |
| Kuboi, M | 1 |
| Sasaki, N | 2 |
| Saito, K | 2 |
| Ubhi, SS | 1 |
| McCulloch, P | 1 |
| Veitch, PS | 1 |
| Hosch, WP | 1 |
| Rudi, J | 1 |
| Stremmel, W | 1 |
| van der Vange, N | 1 |
| Witkamp, AJ | 2 |
| Kaag, MM | 2 |
| Boot, H | 1 |
| Beijnen, JH | 1 |
| Shimada, Y | 1 |
| Yamamoto, M | 1 |
| Nakajima, J | 1 |
| de Bree, E | 1 |
| van Slooten, GW | 1 |
| van Coevorden, F | 1 |
| Yan, H | 1 |
| Pestieau, SR | 1 |
| Shmookler, BM | 1 |
| Kuroki, Y | 1 |
| Otagiri, S | 1 |
| Tsukada, K | 1 |
| Butterworth, SA | 1 |
| Panton, ON | 1 |
| Klaassen, DJ | 1 |
| Shah, AM | 1 |
| McGregor, GI | 1 |
| Kitamura, K | 1 |
| Hagiwa, A | 1 |
| Sakuyama, H | 1 |
| Yamaguchi, T | 1 |
| Takahashi, T | 1 |
| Matsuoka, Y | 1 |
| Ohtomo, K | 1 |
| Itai, Y | 1 |
| Nishikawa, J | 1 |
| Yoshikawa, K | 1 |
| Sasaki, Y | 1 |
| Landy, D | 1 |
| Jaffe, G | 1 |
| Pascal, R | 1 |
| Kern, K | 1 |
| Lack, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Recurrence in Patients With High-risk Colorectal and Appendiceal Neoplasms : a Pilot Study[NCT05623787] | 30 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for mitomycin and Ascites, Gelatinous
| Article | Year |
|---|---|
Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review.
Topics: Appendiceal Neoplasms; Cytoreduction Surgical Procedures; Humans; Hyperthermia, Induced; Mitomycin; | 2020 |
Pseudomyxoma Peritonei: Case Report and Literature Review.
Topics: Appendiceal Neoplasms; Appendix; Biopsy; Colectomy; Combined Modality Therapy; Cytoreduction Surgica | 2019 |
Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms.
Topics: Antibiotics, Antineoplastic; Appendiceal Neoplasms; Australia; Chemotherapy, Cancer, Regional Perfus | 2019 |
[Peritoneal tumor pathology: case n(o) 2: a "sticky" peritoneal tumor].
Topics: Abdominal Pain; Adult; Antineoplastic Agents, Alkylating; Appendectomy; Appendiceal Neoplasms; Combi | 2015 |
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; | 2005 |
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Combined Modality Therapy; Fl | 2006 |
Management of pseudomyxoma peritonei.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Hyperthermia, Indu | 2006 |
4 trials available for mitomycin and Ascites, Gelatinous
| Article | Year |
|---|---|
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Feasibility | 2013 |
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antige | 2008 |
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 2003 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas | 2006 |
61 other studies available for mitomycin and Ascites, Gelatinous
| Article | Year |
|---|---|
Cytoreductive surgery and concomitant hyperthermic thoracoabdominal chemotherapy for pseudomyxoma peritonei with abdominal and pleural involvement.
Topics: Combined Modality Therapy; Cytoreduction Surgical Procedures; Humans; Hyperthermia, Induced; Mitomyc | 2022 |
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Topics: Appendiceal Neoplasms; Bevacizumab; Capecitabine; Disease Progression; Humans; Hyperthermia, Induced | 2023 |
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei.
Topics: Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Cystadenocarcinoma, Mucinous; Cytor | 2019 |
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasm | 2020 |
Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Humans; Hypertherm | 2020 |
Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei.
Topics: Adenocarcinoma, Mucinous; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Appendicitis; Bi | 2020 |
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cy | 2021 |
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Cy | 2021 |
Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Cytoreduction Surgical Procedur | 2017 |
A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?
Topics: Adult; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermia, I | 2019 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Topics: Antineoplastic Agents, Alkylating; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; | 2018 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Carcinoma; Colorectal Neoplasms; Co | 2013 |
Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.
Topics: Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; | 2013 |
Controversy and consensus on the management of patients with pseudomyxoma peritonei.
Topics: Carcinoma; Combined Modality Therapy; Diagnosis, Differential; Humans; Mitomycin; Neoplasm Staging; | 2013 |
Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Hypert | 2013 |
Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Cisplatin; Cohort Stu | 2014 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Transfusio | 2014 |
Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appendiceal Neoplas | 2015 |
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CDX2 Transcri | 2015 |
The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Cisplatin; Colorectal Neoplas | 2015 |
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferati | 2015 |
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Prolifera | 2015 |
Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy P | 2016 |
Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Cytoreduction Surgical Procedures; Female; | 2016 |
Digital Glissonectomy: A Safe Perihepatic Peritonectomy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cispla | 2016 |
Advanced Pseudomyxoma Peritonei Requiring Gastrectomy to Achieve Complete Cytoreduction Results in Good Long-Term Oncologic Outcomes.
Topics: Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; CA-125 Antigen; CA-19-9 Antigen; Carcinoem | 2016 |
Outcome and surgical strategy in critical sites in cases of psuedomyxoma peritonei.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytoreduction Surg | 2016 |
Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2017 |
Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Female; H | 2009 |
Sugarbaker procedure for pseudomyxoma peritonei.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Digestive System Surgical Procedures; Humans | 2009 |
Simultaneous bicavitary hyperthermic chemoperfusion in the management of pseudomyxoma peritonei with synchronous pleural extension.
Topics: Antibiotics, Antineoplastic; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Ag | 2009 |
Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; France; Humans; H | 2010 |
Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Topics: Adult; Antineoplastic Agents; Cell Differentiation; Cell Transformation, Neoplastic; Disease Progres | 2010 |
Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Humans; Hyperthermia, Induced; Mito | 2011 |
Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Blood | 2012 |
Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 2011 |
Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Agents; Female; Fluorouracil; Humans; Male; Middle Aged; M | 2004 |
Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2005 |
Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 2005 |
Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcin | 2005 |
An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Cisplatin; Containment of Bio | 2005 |
Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined | 2006 |
Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Topics: Adult; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemothera | 2007 |
Interstitial pneumonitis: an exceptional toxicity of hyperthermic intraperitoneal mitomycin C.
Topics: Antibiotics, Antineoplastic; Appendiceal Neoplasms; Female; Humans; Hyperthermia, Induced; Infusions | 2008 |
Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; | 2007 |
Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Biomarker | 2008 |
[Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1996 |
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Topics: Abdomen; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Chemotherapy, | 1996 |
Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy.
Topics: Adenocarcinoma; Adsorption; Aged; Antibiotics, Antineoplastic; Carbon; Female; Humans; Male; Middle | 1997 |
Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Chemotherapy, Ad | 1999 |
[Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
Topics: Antibiotics, Antineoplastic; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Dose-Response R | 1999 |
[Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Cisplati | 1999 |
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2001 |
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; | 2001 |
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Digestive Syste | 2001 |
Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Combined Modality Therapy; Diagn | 2001 |
Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Digestive System S | 2002 |
A new chemotherapy against pseudomyxoma peritonei.
Topics: Carbon; Female; Humans; Injections, Intraperitoneal; Middle Aged; Mitomycin; Pseudomyxoma Peritonei; | 1992 |
Pseudomyxoma peritonei with progressive calcifications: CT findings.
Topics: Adult; Aged; Calcinosis; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomyci | 1992 |
Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Colonic Neoplasm | 1990 |
Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combina | 1987 |